International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
Clinical Management Of Generalized Anxiety Disorder (Chittodvega) Through Shirodhara With Mamsyadi Kwatha: A Comprehensive Case Report
| Author(s) | Dr. Ayushi Chandil, Dr. Shraddha Sharma, Dr. Pooja Maida, Prof. Dr. Rajesh Meshram |
|---|---|
| Country | India |
| Abstract | Background: Generalized Anxiety Disorder (GAD), structurally mapped to Chittodvega in Ayurvedic nosology, stems from a combined aggravation of Vata-Pitta Doshas alongside an elevation of Rajas and Tamas in the Manovaha Srotas. Standard psychopharmacological agents are often associated with dependency, sedation, and adverse cognitive effects.Case Presentation: A 34-year-old adult with a 7-month history of GAD, meeting DSM-5 diagnostic criteria, was managed with Shirodhara using warm Mamsyadi Kwatha (38–40°C) — a neuro-restorative decoction of Nardostachys jatamansi, Withania somnifera, and Hyoscyamus niger — administered daily for 30-minute sessions over 21 consecutive days.Outcome Measures: Symptom severity and sleep quality were assessed at Baseline (Day 0), Mid-Treatment (Day 10), and End of Treatment (Day 21) using the Hamilton Anxiety Rating Scale (HAM-A) and the Pittsburgh Sleep Quality Index (PSQI).Results: Total HAM-A score decreased from 28 at baseline to 10 at Day 21 (64% reduction), with psychic and somatic anxiety subscale scores improving by 68% and 59% respectively. The global PSQI score dropped from 14 to 5 (62% reduction), with sleep latency reduced from 52 to 18 minutes. No adverse events were observed.Conclusion: Shirodhara with Mamsyadi Kwatha provided a safe, multi-targeted intervention that dampened central nervous hyperarousal, restored autonomic equilibrium, and alleviated both somatic and psychic components of Chittodvega, suggesting potential as a non-pharmacological adjunct in GAD management. |
| Keywords | Chittodvega; Generalized anxiety disorder; Mamsyadi Kwatha; Nardostachys jatamansi; Shirodhara; Sthapani Marma. |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 4, July-August 2026 |
| Published On | 2026-08-19 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i04.85625 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals